Firefly Neuroscience Inc (NASDAQ:AIFF)’s traded shares stood at 0.74 million during the latest session, with the company’s beta value hitting 3.05. At the last check today, the stock’s price was $3.89, to imply an increase of 5.14% or $0.19 in intraday trading. The AIFF share’s 52-week high remains $15.90, putting it -308.74% down since that peak but still an impressive 52.19% since price per share fell to its 52-week low of $1.86. The company has a valuation of $30.91M, with an average of 14.07 million shares in intraday trading volume over the past 10 days and average of 2.49 million shares over the past 3 months.

Firefly Neuroscience Inc (NASDAQ:AIFF) trade information

After registering a 5.14% upside in the latest session, Firefly Neuroscience Inc (AIFF) has traded red over the past five days. The 5-day price performance for the stock is 64.83%, and 24.28% over 30 days. With these gigs, the year-to-date price performance is 46.79%. Short interest in Firefly Neuroscience Inc (NASDAQ:AIFF) saw shorts transact 0.4 million shares and set a 0.87 days time to cover.

AIFF Dividends

Firefly Neuroscience Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Firefly Neuroscience Inc (NASDAQ:AIFF)’s Major holders

We also have Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Firefly Neuroscience Inc (AIFF) shares. Going by data provided on Nov 30, 2024, Fidelity Extended Market Index Fund holds roughly 33.16 shares. This is just over 0.42% of the total shares, with a market valuation of $0.13 million. Data from the same date shows that the other fund manager holds a little less at 11.27, or 0.14% of the shares, all valued at about 44013.0.